Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biohaven Ltd (BHVN)

Biohaven Ltd (BHVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biohaven Ltd 215 CHURCH STREET NEW HAVEN CT 06510 USA

www.biohaven.com Employees: 239 P: 203-404-0410

Description:

Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut.

Key Statistics

Overview:

Market Capitalization, $K 3,666,684
Enterprise Value, $K 3,418,284
Shares Outstanding, K 101,122
Annual Sales, $ 0 K
Annual Net Income, $ -408,170 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -160,300 K
EBIT, $ -848,890 K
EBITDA, $ -841,980 K
60-Month Beta 1.24
% of Insider Shareholders 16.00%
% of Institutional Shareholders 88.78%
Float, K 84,942
% Float 84.00%
Short Volume Ratio 0.77

Growth:

1-Year Return -4.38%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 6.83%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.70 on 11/12/24
Next Earnings Date N/A
Earnings Per Share ttm -9.35
EPS Growth vs. Prev Qtr 53.30%
EPS Growth vs. Prev Year -13.33%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

BHVN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -225.12%
Return-on-Assets % -158.89%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 10.57
Book Value/Share 3.34
Interest Coverage -5.52
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar